The Lancet. Respiratory medicine
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis.
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Is neutrophilic inflammation treatable in COVID-19?
Opportunities for improved clinical trial designs in acute respiratory distress syndrome.
Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome.
Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19.
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Immunotherapy in COVID-19: why, who, and when?
The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included?
Geography, generalisability, and susceptibility in clinical trials.
